| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |